| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 5.590 | 5.371 | 5.131 | 8.633 | 10.594 | 11.621 |
| Total Income - EUR | - | - | - | - | 5.590 | 5.371 | 5.131 | 8.633 | 10.594 | 11.621 |
| Total Expenses - EUR | - | - | - | - | 2.022 | 858 | 723 | 844 | 1.240 | 1.016 |
| Gross Profit/Loss - EUR | - | - | - | - | 3.568 | 4.513 | 4.407 | 7.790 | 9.354 | 10.605 |
| Net Profit/Loss - EUR | - | - | - | - | 3.463 | 4.384 | 4.266 | 7.580 | 8.094 | 8.942 |
| Employees | - | - | - | - | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dermabac S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 3.534 | 7.847 | 11.941 | 7.665 | 8.467 | 9.250 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 316 | 198 | 24 | 2.636 | 263 | 462 |
| Cash | - | - | - | - | 3.218 | 7.648 | 11.917 | 5.029 | 8.204 | 8.787 |
| Shareholders Funds | - | - | - | - | 3.505 | 7.822 | 11.915 | 7.621 | 8.136 | 8.991 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 29 | 24 | 26 | 44 | 331 | 259 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermabac S.r.l.